Nkarta (NKTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NKTX Nkarta

Watchlist

2.340
+0.050+2.18%

Close Dec 13 16:00 ET

2.350
+0.010+0.42%

Post 16:31 ET

165.13MMarket Cap-1.28P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Nkarta Opens Enrolment, Receives Clearance for Autoimmune Diseases Therapy Trials
MT NewswiresDec 5 07:17 ET
Nkarta's Ntrust-2 Trial of NKX019 in Myasthenia Gravis Begins Enrollment
TipRanksDec 5 06:15 ET
Express News | Nkarta Inc: Clinical Data From Ntrust-1 and Ntrust-2 Planned for 2025
ReutersDec 5 06:01 ET
Express News | Nkarta Announces Ind Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
ReutersDec 5 06:01 ET
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
NkartaDec 5 00:00 ET
Nkarta to Participate in an Upcoming Investor Conference
NkartaNov 26 00:00 ET

Comments

70205719

Dec 10 14:35

$Nkarta (NKTX.US)$
morning star? bottom now with big vol. buy now?

Jaguar8

Dec 5 05:09

NEWS

$Nkarta (NKTX.US)$
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
Nkarta (NKTX) announced the opening of enrollment for Ntrust-2 and IND clearance for an investigator-sponsored trial (IST) evaluating NKX019, their allogeneic CD19-directed CAR NK-cell therapy. Ntrust-2 will evaluate the treatment across three parallel cohorts: systemic sclerosis, myositis, and ANCA-associated vasculitis. The IST will study NKX019 in my...

Trytosaveabit

Dec 5 05:04

News

$Nkarta (NKTX.US)$ Reuters· 2 mins ago
Nkarta Announces Ind Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

iamiam

Nov 11 09:54

$Nkarta (NKTX.US)$
boom boom boom boom 💥 getting richer from my room 🤣
$Nkarta (NKTX.US)$
$Nkarta (NKTX.US)$

Unsupported feature. Please use the mobile app.

Share Your Profit/Loss

iamiam

Oct 31 00:15

$Nkarta (NKTX.US)$
I don't know why I didn't share it in my previous post or why I just thought to share it now 🤷🏽 but here we go. this is what I shared with the group.
I know i said not to buy ibrx because it was too volatile. I've changed my tune because of my biopharma outlook.... want it's twin?
cancer killing cell developer, starting with leukemia! buy rating at 17 (i think it pops to 23, but 19 is the full extension) 👌
see that daily turnaround? that's a bottom
see the accumulation at th...

Unsupported feature. Please use the mobile app.

Heat List

Overall

No Data